Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $91.4500 (-0.64%) ($90.0900 - $94.4100) on Thu. Oct. 29, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.57% (three month average) | RSI | 56 | Latest Price | $91.4500(-0.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) XBI(57%) IWO(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.785% in a week (0% probabilities). VIXM(-17%) TLT(-15%) UUP(-6%) GDXJ(-5%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.785% (StdDev 3.57%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
5 Day Moving Average | $90.88(0.63%) | 10 Day Moving Average | $90.33(1.24%) | 20 Day Moving Average | $89.68(1.97%) | To recent high | -10.3% | To recent low | 11.4% | Market Cap | $1.47b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |